医学
荟萃分析
尿失禁
性功能
外科
金标准(测试)
梅德林
内科学
政治学
法学
作者
Andrea Lombisani,Veronica Tius,Chiara Ferraro,Martina Arcieri,Lorenzo Vacca,Daniela Caramazza,Stefano Restaino,Tommaso Simoncini,Giampiero Capobianco,Alfredo Ercoli,Giovanni Scambia,Giuseppe Vizzielli,Giuseppe Campagna
标识
DOI:10.1007/s00404-025-08210-4
摘要
Abstract Purpose Although sacral colpopexy is considered the gold standard for correcting apical prolapse, it is associated with extended operative times and surgical complications. An alternative surgical approach is currently being investigated. This meta-analysis aims to summarize and compare the available data on laparoscopic sacral colpopexy (LSCP) and laparoscopic lateral suspension (LLS) as per the Dubuisson technique. Methods A systematic search of PubMed (MEDLINE) and Google Scholar was conducted from the inception of each database until December 2024. Studies comparing LSCP and LLS on at least one efficacy outcome selected. Objective or subjective success rate, surgery-related data and follow-up data were extracted. Results were pooled using a random-effect meta-analysis. Results A total of 6 studies were included. The meta-analysis did not report statistical differences between LSCP and LLS in terms of apical prolapse [OR = 1.24; CI 95% (0.61, 2.52); I 2 = 0%; P = 0.55] and anterior prolapse [OR = 0.78; CI 95% (0.45, 1.37); I 2 = 0%; P = 0.39] correction. Subjective success rate was similar ( P = 0.72). LLS required shorter operative time [43.1 min, CI 95% (16.75, 69.45); I 2 = 97%; P = 0.001]. No major differences were found regarding intraoperative and early post-operative complications, re-operation and recurrence rates. Follow-up data regarding quality of life showed no significant differences about de novo stress urinary incontinence, intestinal impairment, sexual function, and pain after surgery. Conclusions LLS provides similar outcomes to LSCP for apical and anterior prolapse in selected cases. However, limited long-term data and few studies on advanced prolapse prevent LLS from being declared an equally effective alternative at this time. PROSPERO registration number CRD42024537270.
科研通智能强力驱动
Strongly Powered by AbleSci AI